Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Mirago 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Mirabegron (25mg)

Overview Mirago 25 Tablet ER

Extended-release Mirago 25mg tablets alleviate overactive bladder symptoms such as urinary urgency, frequency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration. Mirago 25mg ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Common side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report persistent or bothersome side effects to your doctor immediately. Before starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.

Uses of Mirago 25 Tablet ER

Managing overactive bladder (OAB) symptoms

Major Benefits of Mirago 25 Tablet ER:

Consume Mirago 25 ER tablets precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. While ingestion with or without food is acceptable, consistency in administration time is recommended.

Common Side effects of Mirago 25 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Mirago 25 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirago 25 Tablet ER can be administered with or without food, though consistent timing is recommended.

How Mirago 25 Tablet ER works:

Mirago 25 Extended-Release tablets contain a beta-3 adrenergic agonist. This medication relaxes bladder muscles by stimulating specific receptors within the bladder wall, thereby reducing urinary frequency, urgency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Mirago 25 Tablet ER with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mirago 25mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Mirago 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mirago 25 ER tablets.

KidneyKidneyCAUTION

Extended-release Mirago 25mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification of Mirago 25mg extended-release tablets might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Mirago 25 ER tablets; dosage modification may be necessary. Consultation with a physician is advised. Mirago 25 ER tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Mirago 25 Tablet ER :

Should you forget a Mirago 25 Tablet ER dose, take it immediately. If your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Mirago 25 Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Treatment Category Urology
Actions Beta-3 agonist for bladder control

FAQs on Mirago 25 Tablet ER

Mirago 25 Tablet ER's full effects may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4 to 8 weeks, depending on individual response.
Continue taking Mirago 25 Tablet ER even if your symptoms improve. This medication doesn't cure overactive bladder; it manages urgency, frequent urination, and incontinence. Discontinuing treatment could cause your symptoms to return.
Mirago 25 Tablet ER shouldn't interfere with your sleep. Consult your doctor about any sleep issues.
Mirago 25 Tablet ER shouldn't be given to children under 18, as its safety and efficacy haven't been established in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not curing it. Intermittent use prevents your bladder from adapting fully, hindering effectiveness and leading to symptom recurrence.
Mirago 25 Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain have been reported rarely. Patients with impaired kidney function should use caution and promptly report any kidney-related adverse effects to their doctor.
Caution is advised when taking Mirago 25 Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended, as this medication may raise blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of symptoms. Mirago 25 Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Mirago 25 Tablet ER
215
MRP 262
17% off